HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ioannis Mylonas Selected Research

Activins (Activin)

5/2016Expression of Activin During and After Chemotherapy in Peripheral Blood of Patients with Primary Breast Cancer.
8/2011Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
7/2011Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer.
7/2011Inhibin/activin betaE-subunit in uterine endometrioid adenocarcinoma and endometrial cancer cell lines: from immunohistochemistry to clinical testing?
3/2011Inhibin-α subunit expression in uterine endometrioid adenocarcinomas and endometrial cancer cell lines: a potential prognostic factor.
2/2011Inhibin/activin-betaE subunit is expressed in normal and pathological human placental tissue including chorionic carcinoma cell lines.
1/2011Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines.
9/2010Inhibin/activin-betaC subunit in human endometrial adenocarcinomas and HEC-1a adenocarcinoma cell line.
8/2010Immunohistochemical labeling of the inhibin/activin betaC subunit in normal human placental tissue and chorionic carcinoma cell lines.
8/2010Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ioannis Mylonas Research Topics

Disease

39Neoplasms (Cancer)
01/2017 - 05/2005
20Breast Neoplasms (Breast Cancer)
05/2016 - 11/2004
18Carcinoma (Carcinomatosis)
10/2013 - 11/2004
17Endometrial Neoplasms (Endometrial Cancer)
01/2012 - 07/2007
12Endometrioid Carcinoma
01/2012 - 05/2005
11Neoplasm Metastasis (Metastasis)
12/2014 - 01/2005
11Carcinogenesis
10/2011 - 01/2005
10Adenocarcinoma
10/2013 - 01/2003
9Ovarian Neoplasms (Ovarian Cancer)
07/2014 - 09/2008
7Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2013 - 10/2009
6Lymphatic Metastasis
05/2010 - 01/2005
5Infections
05/2012 - 01/2009
5Ductal Carcinoma
05/2009 - 01/2005
5Pre-Eclampsia (Preeclampsia)
01/2009 - 12/2005
5Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007 - 01/2005
5Carcinoma in Situ
07/2007 - 03/2005
3Hemolysis
08/2011 - 11/2006
3Spontaneous Abortion (Miscarriage)
04/2011 - 05/2008
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
07/2007 - 05/2005
3Hyperplasia
01/2006 - 01/2003
3Polyps
06/2005 - 01/2003
2Leukemia
01/2017 - 10/2014
2Multiple Sclerosis
01/2015 - 01/2014
2Communicable Diseases (Infectious Diseases)
01/2014 - 01/2011
2Fetal Growth Retardation (Intrauterine Growth Retardation)
08/2011 - 07/2007
2Hypersensitivity (Allergy)
01/2011 - 05/2009
2Hydatidiform Mole (Molar Pregnancy)
05/2008 - 07/2007
2Breast Ductal Carcinoma
07/2007 - 05/2005
2HELLP Syndrome
07/2007 - 02/2007
1Amenorrhea
05/2016

Drug/Important Bio-Agent (IBA)

27Inhibins (Inhibin)IBA
10/2013 - 01/2005
20Activins (Activin)IBA
05/2016 - 01/2005
16ParaffinIBA
05/2010 - 01/2003
11Estrogen Receptor alphaIBA
11/2010 - 12/2005
9Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2005
9Monoclonal AntibodiesIBA
09/2010 - 01/2005
9GlycodelinIBA
05/2010 - 03/2005
7Hormones (Hormone)IBA
12/2014 - 07/2007
7Cadherins (E-Cadherin)IBA
12/2014 - 05/2005
7Steroid Receptors (Steroid Receptor)IBA
05/2010 - 05/2005
6Estrogen ReceptorsIBA
12/2014 - 07/2007
6Tumor Biomarkers (Tumor Markers)IBA
07/2014 - 01/2005
5Pharmaceutical PreparationsIBA
01/2014 - 01/2010
5Estrogen Receptor betaIBA
09/2008 - 12/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2011
4EnzymesIBA
12/2014 - 11/2006
4Anti-Bacterial Agents (Antibiotics)IBA
10/2014 - 01/2010
4inhibin beta A subunitIBA
10/2011 - 01/2005
4AntibodiesIBA
05/2011 - 05/2005
3Messenger RNA (mRNA)IBA
10/2013 - 03/2005
3Drug CombinationsIBA
02/2013 - 01/2010
3Nelfinavir (Viracept)FDA Link
10/2012 - 01/2010
3Peptide Hormones (Polypeptide Hormones)IBA
10/2011 - 10/2010
3inhibin-alpha subunitIBA
09/2010 - 07/2007
3Peptides (Polypeptides)IBA
05/2010 - 05/2005
3TamoxifenFDA LinkGeneric
01/2010 - 01/2003
3Sialyl Lewis X AntigenIBA
02/2009 - 05/2005
3progesterone receptor AIBA
01/2009 - 07/2007
2AnnexinsIBA
01/2017 - 01/2010
2Glycoproteins (Glycoprotein)IBA
05/2016 - 01/2007
2Interferon beta-1b (Betaseron)FDA Link
01/2015 - 01/2014
2Pemetrexed (MTA)FDA Link
12/2014 - 07/2009
2Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2013 - 06/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2012 - 05/2011
2HIV Protease InhibitorsIBA
06/2010 - 01/2010
2CytokinesIBA
07/2009 - 09/2008
2Mucin-1 (CA 15-3 Antigen)IBA
05/2009 - 07/2007
2EpitopesIBA
05/2009 - 05/2005
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2008 - 07/2007
2Cathepsin DIBA
07/2007 - 05/2005
2Progesterone Receptors (Progesterone Receptor)IBA
07/2007 - 07/2007
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
07/2007 - 05/2005
2ProgesteroneFDA LinkGeneric
07/2007 - 07/2007
2Hydrocortisone (Cortisol)FDA LinkGeneric
07/2007 - 07/2007
2Formaldehyde (Formol)FDA Link
07/2007 - 05/2005
2Neoplasm Antigens (Tumor Antigens)IBA
07/2007 - 05/2005
2Estrogens (Estrogen)FDA Link
07/2007 - 07/2007
2Estradiol (Delestrogen)FDA LinkGeneric
07/2007 - 07/2007
2SteroidsIBA
07/2007 - 07/2007
2Lewis Blood Group AntigensIBA
07/2007 - 05/2005
1NucleosidesIBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1CaspasesIBA
01/2017
1Reverse Transcriptase InhibitorsIBA
01/2017
1efavirenz (Sustiva)FDA Link
01/2017
1activin AIBA
05/2016
1activin BIBA
05/2016
1Histones (Histone)IBA
12/2014
1borrelidinIBA
10/2014
1MacrolidesIBA
10/2014
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2014
1Biomarkers (Surrogate Marker)IBA
07/2014
1TetracyclinesIBA
01/2014
1Disulfiram (Antabuse)FDA Link
01/2014

Therapy/Procedure

13Therapeutics
05/2012 - 06/2007
3Drug Therapy (Chemotherapy)
05/2016 - 09/2007
3Cesarean Section (Caesarean Section)
08/2011 - 01/2009
2Lymph Node Excision (Lymph Node Dissection)
01/2012 - 05/2010
2Mastectomy (Mammectomy)
11/2008 - 06/2007
1Adjuvant Chemotherapy
05/2016